COVID-19 AstraZeneca’s Vaxzevria receives full Marketing Authorization in the EU Malin Otmani November 7, 2022
COVID-19 Bavarian Nordic provides update on its COVID-19 booster vaccine candidate Malin Otmani June 21, 2022
COVID-19 New findings on the benefits of mRNA booster vaccines in developing countries Malin Otmani May 16, 2022
COVID-19 741 Views He is the Director of the new Health Emergency and Pandemic Science Center Malin Otmani March 4, 2022 Johan von Schreeb, Professor of…
COVID-19 885 Views New insight into NK cells’ reaction to COVID-19 Malin Otmani February 22, 2022 An international team of scientist…
COVID-19 847 Views Oestrogen may protect against death in COVID-19 Malin Otmani February 18, 2022 The female sex hormone oestrogen…
Clinical Trials 1062 Views Vicore Pharma announces new data Malin Otmani February 11, 2022 Vicore Pharma has announced data…
COVID-19 710 Views COVID-19 vaccine-induced protection wanes at different speed Malin Otmani February 7, 2022 The vaccine-induced protection against SARS-CoV-2…
COVID-19 806 Views BerGenBio’s bemcentinib will be studied in the EU-SolidAct trial Malin Otmani January 31, 2022 BerGenBio and Oslo University Hospital…
COVID-19 797 Views Research shows persistent T cell response to omicron after infection and vaccination Malin Otmani January 19, 2022 A new study from Karolinska…
COVID-19 674 Views COVID-19 smell and taste loss may have genetic link Malin Otmani January 19, 2022 Scientists have identified some genetic…
COVID-19 834 Views First subject dosed with Nykode’s vaccine candidate Malin Otmani January 19, 2022 Nykode Therapeutics has announced that…
COVID-19 853 Views Protective gene variant against COVID-19 discovered Malin Otmani January 14, 2022 An international metastudy led by…
COVID-19 818 Views Novavax’s vaccine granted conditional marketing authorization Malin Otmani December 21, 2021 The European Commission (EC) has…
COVID-19 938 Views Sobi’s Kinaret receives positive opinion from the CHMP Malin Otmani December 20, 2021 The Committee for Medicinal Products…
COVID-19 707 Views New results from Cyxone’s phase 2 study of Rabeximod Malin Otmani December 14, 2021 Cyxone has announced results from…
COVID-19 634 Views AstraZeneca’s Evusheld receives EUA in the US Malin Otmani December 14, 2021 Evusheld (formerly AZD7442) long-acting antibody…
COVID-19 1494 Views AstraZeneca’s new COVID-19 drug to be manufactured in Sweden Malin Otmani December 13, 2021 The last manufacturing steps of…
COVID-19 708 Views EMA issues advice on use of molnupiravir for COVID-19 treatment Malin Otmani November 22, 2021 EMA’s human medicines committee (CHMP)…